Translational Bioinformatics Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimers Disease (R01 Clinical Trial Optional)

Funding Opportunity PAR-20-156 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) enables data-driven drug repositioning and combination therapy for Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD) by developing computational methods and data resources and/or integrating computational approaches with proof-of-concept efficacy studies in cell-based models, animal models, and/or humans.

http://grants.nih.gov/grants/guide/pa-files/PAR-20-156.html

Source: NIH Funding Opportunities (Notices, PA, RFA) - March 31, 2020 Category: Research Source Type: funding